Unknown

Dataset Information

0

Genetic ancestry plays a central role in population pharmacogenomics.


ABSTRACT: Recent studies have pointed out the essential role of genetic ancestry in population pharmacogenetics. In this study, we analyzed the whole-genome sequencing data from The 1000 Genomes Project (Phase 3) and the pharmacogenetic information from Drug Bank, PharmGKB, PharmaADME, and Biotransformation. Here we show that ancestry-informative markers are enriched in pharmacogenetic loci, suggesting that trans-ancestry differentiation must be carefully considered in population pharmacogenetics studies. Ancestry-informative pharmacogenetic loci are located in both protein-coding and non-protein-coding regions, illustrating that a whole-genome analysis is necessary for an unbiased examination over pharmacogenetic loci. Finally, those ancestry-informative pharmacogenetic loci that target multiple drugs are often a functional variant, which reflects their importance in biological functions and pathways. In summary, we develop an efficient algorithm for an ultrahigh-dimensional principal component analysis. We create genetic catalogs of ancestry-informative markers and genes. We explore pharmacogenetic patterns and establish a high-accuracy prediction panel of genetic ancestry. Moreover, we construct a genetic ancestry pharmacogenomic database Genetic Ancestry PhD ( http://hcyang.stat.sinica.edu.tw/databases/genetic_ancestry_phd/ ).

SUBMITTER: Yang HC 

PROVIDER: S-EPMC7864978 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genetic ancestry plays a central role in population pharmacogenomics.

Yang Hsin-Chou HC   Chen Chia-Wei CW   Lin Yu-Ting YT   Chu Shih-Kai SK  

Communications biology 20210205 1


Recent studies have pointed out the essential role of genetic ancestry in population pharmacogenetics. In this study, we analyzed the whole-genome sequencing data from The 1000 Genomes Project (Phase 3) and the pharmacogenetic information from Drug Bank, PharmGKB, PharmaADME, and Biotransformation. Here we show that ancestry-informative markers are enriched in pharmacogenetic loci, suggesting that trans-ancestry differentiation must be carefully considered in population pharmacogenetics studies.  ...[more]

Similar Datasets

| S-EPMC3168175 | biostudies-literature
| S-EPMC4935730 | biostudies-literature
| S-EPMC6609213 | biostudies-literature
| S-EPMC374338 | biostudies-literature
2019-08-29 | GSE136566 | GEO
| S-EPMC3104508 | biostudies-literature
| S-EPMC7346075 | biostudies-literature
2021-10-20 | GSE175794 | GEO
| S-EPMC8565749 | biostudies-literature
| S-EPMC4248356 | biostudies-literature